Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Inspira Technologies wins $596,000 order for AME system from Irish research university
Inspira Technologies has secured a $596,000 order for an AME system (additive manufacturing of electronics) from an Irish technological research university. The company received a non‑refundable 40% advance payment, with the remainder due on delivery. The order includes recurring revenue from consumables, wear parts and annual service fees; delivery, installation and training are planned in the coming weeks and are intended to serve as a reference for further academic and commercial collaborations in Europe. Inspira has a market capitalization of $19.28 million and annual revenue of $290,000. » Más en de.investing.com
Inspira Technologies enters quantum computing and plans to rebrand as QTREX
Inspira Technologies announces a strategic entry into the quantum computing sector and aims to use its additively manufactured AME platform to address 3D connectivity issues in dilution cryostats to improve qubit coherence and system stability. The company, led by CEO Dagi Ben-Noon and COO Avi Shabtay, reports a proof of concept for integrating qubit-relevant components and is negotiating partnerships but provides no details or timelines. Inspira plans to continue its medical technology division as a subsidiary, intends to change its name to QTREX, and points to large market forecasts, but remains financially unprofitable and shows high cash outflows. » Más en de.investing.com
Inspira Technologies terminates two financing agreements
Inspira Technologies announces the written termination of its sales agreement with A.G.P./Alliance Global Partners dated 17 February 2026 and its standby equity purchase agreement with YA II PN, Ltd. dated 12 December 2025. The company has no outstanding obligations under either agreement and no further payments will be made. Inspira cites the goal of a disciplined capital structure as the reason for the move while it prepares for the next strategic phase; the stock has recently fallen sharply and, according to InvestingPro, is fairly valued. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | junio de 2025 | YoY |
|---|---|---|
| Ingresos | 122,6 mil | - |
| Beneficio bruto | 848,42 | - |
| Beneficio neto | -2,71 M | - |
| EBITDA | -3,04 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 22,55 M € |
Número de acciones | 24,08 M |
Máximo/mínimo de 52 semanas | 1,87 € - 0,30 € |
| Dividendos | No |
Beta | 2,33 |
Ratio P/E | - |
Ratio PEG | - |
Ratio P/B | - |
Ratio P/S | - |
Perfil de la empresa
Inspira Technologies Oxy B.H.N. Ltd., una empresa de dispositivos médicos especializados, se dedica a la investigación, el desarrollo, la fabricación y la comercialización de tecnología de soporte respiratorio para ofrecer una alternativa a la ventilación mecánica invasiva (MV) en el tratamiento de la insuficiencia respiratoria. Su producto principal es el sistema de tecnología de respiración aumentada (ART), un sistema de soporte respiratorio que comprende una cánula de doble luz portátil y mínimamente invasiva, que se inserta en la vena yugular y utiliza la oxigenación directa de la sangre extracorpórea para elevar y estabilizar los niveles decrecientes de saturación de oxígeno. La empresa era conocida anteriormente como Insense Medical Ltd. y cambió su nombre a Inspira Technologies Oxy B.H.N. Ltd. en julio de 2020. La empresa se constituyó en 2018 y tiene su sede en Ra'annana, Israel.
| Nombre | INSPIRA TECH OXY IS-,125 Aktie |
| CEO | Dagi Shahar Ben-Noon |
| Sede | Ra'anana,
Israel |
| Sitio web | |
| Sector | Consumo discrecional |
| Industria | Bienes duraderos del hogar |
| Salida a bolsa | 14/07/2021 |
| Empleados | 39 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | IINN |